These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 2836525
1. Intradermal treatment of cutaneous leishmaniasis with two antimonial drugs. Morsy TA, Essa MH, Aboul Anaan AM, Montasser MF. J Egypt Soc Parasitol; 1988 Jun; 18(1):341-4. PubMed ID: 2836525 [No Abstract] [Full Text] [Related]
2. On the treatment of cutaneous leishmaniasis in Egypt. Morsy TA, Abdel Wahab RM, Essa MH, Ramadan NF, Helmy OM. J Egypt Soc Parasitol; 1986 Dec; 16(2):621-8. PubMed ID: 3023501 [No Abstract] [Full Text] [Related]
3. New delivery strategies for the old pentavalent antimonial drugs. Frézard F, Demicheli C. Expert Opin Drug Deliv; 2010 Dec; 7(12):1343-58. PubMed ID: 21029028 [Abstract] [Full Text] [Related]
4. [Cutaneous leishmaniasis]. Vion B. Rev Med Suisse Romande; 1989 Jun; 109(6):443-9. PubMed ID: 2547241 [No Abstract] [Full Text] [Related]
5. Treatment of cutaneous leishmaniasis in Saudi Arabia. Fattah AA, Morsy TA, Ismail MA. J Egypt Soc Parasitol; 1983 Jun; 13(1):9-17. PubMed ID: 6313824 [No Abstract] [Full Text] [Related]
6. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases]. Bourée P, Anciaux ML, Taugourdeau P. Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657 [Abstract] [Full Text] [Related]
7. Leishmaniasis recidivans treated with sodium stibogluconate. Schewach-Millet M, Fisher BK, Semah D. Cutis; 1981 Jul; 28(1):67-8, 77, 84 passim. PubMed ID: 6266776 [Abstract] [Full Text] [Related]
8. Effects of antimonial therapy for canine leishmaniasis on antibody titer. Amusategui I, Sainz A, Tesouro MA. Ann N Y Acad Sci; 1998 Jun 29; 849():444-6. PubMed ID: 9668509 [No Abstract] [Full Text] [Related]
9. Recurrent cutaneous leishmaniasis: successful treatment with sodium antimony gluconate. Aram H, el-On J. Cutis; 1986 Mar 29; 37(3):177-9. PubMed ID: 3007035 [Abstract] [Full Text] [Related]
10. [Evaluation of the effectiveness and toxicity of pentostam and glucantime in the treatment of cutaneous leishmaniasis]. Sáenz RE, Paz HM, Johnson CM, Narvaez E, de Vásquez AM. Rev Med Panama; 1987 Sep 29; 12(3):148-57. PubMed ID: 2827242 [No Abstract] [Full Text] [Related]
11. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device. Bogenrieder T, Lehn N, Landthaler M, Stolz W. Dermatology; 2003 Sep 29; 206(3):269-72. PubMed ID: 12673089 [Abstract] [Full Text] [Related]
13. Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam). Kellum RE. J Am Acad Dermatol; 1986 Oct 29; 15(4 Pt 1):620-2. PubMed ID: 3021826 [Abstract] [Full Text] [Related]
14. The irreplaceable image: Acute toxicity in erythroid bone marrow progenitors after antimonial therapy. Hernández JA, Navarro JT, Force L. Haematologica; 2001 Dec 29; 86(12):1319. PubMed ID: 11726328 [No Abstract] [Full Text] [Related]
15. High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis. Marsden PD, Sampaio RN, Carvalho EM, Veiga JP, Costa JL, Llanos-Cuentas EA. Am J Trop Med Hyg; 1985 Jul 29; 34(4):710-3. PubMed ID: 2992304 [Abstract] [Full Text] [Related]